25 results for “mci”. Showing 25 of 39,449.
In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
MCI-LB, but not in MCI-AD. In both MCI
Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers.
MCI) with a common Alzheimer disease (AD) phenotype (cAD-MCI
Platelet proteomic signatures of amyloid β-positive mild cognitive impairment and Alzheimer's disease.
MCI without Aβ deposition (MCI-A(+), n = 5), MCI with
Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
MCI) has been defined as a transitional state between normal
The association of Alzheimer's disease-related SNPs with mild cognitive impairment susceptibility in the Chinese population.
MCI in the Chinese population. We recruited 200 MCI patients
Increased incidence of mild cognitive impairment in long COVID patients.
MCI. The cumulative incidence of MCI was calculated for each
Accuracy of verbal fluency tests in the discrimination of mild cognitive impairment and probable Alzheimer's disease in older Spanish monolingual individuals.
MCI (p < .001), of HC from MCI-AD (p < .001) and of MCI
Neuropsychological and neuroimaging characteristics of patients with mild cognitive impairment and negative-amyloid deposition.
MCI group did. Both MCI subgroups exhibited extensive disruptions of WM integrity
IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment.
MCI). IL-33 and sST2 were analyzed in serum and CSF of AD and MCI
Comparison between physical and cognitive treatment in patients with MCI and Alzheimer's disease.
MCI: -11.8%, AD: -16.2%). Between group differences (MCI vs AD) were
Modeling the age-specific incidence of mild cognitive impairment incorporating the time-varying relationship of Alzheimer's disease biomarkers over 28 years.
MCI onset.ObjectiveTo estimate age-specific incidence rates of MCI onset
Differential diagnosis of mild cognitive impairment of Alzheimer's disease by Simoa p-tau181 measurements with matching plasma and CSF.
MCI subtypes amnestic MCI (aMCI) from non-amnestic MCI (naMCI
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
MCI A + but comparable with MCI A-. Similarly, MCI A + had higher
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
MCI), but large-scale multicenter studies have not been conducted
Circulating levels of IL-1 family cytokines and receptors in Alzheimer's disease: new markers of disease progression?
MCI), subjective memory complaints (SMC), and normal healthy subjects (NHS). Using
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
MCI, whereas the MoCA detected 90% of MCI subjects. In the mild
Lack of association between bridging integrator 1 (
MCI patients. However, in the MCI group, numerically higher [18F]AV1451
Glial activation and inflammation along the Alzheimer's disease continuum.
MCI cases (p < .05). MCP-1 was increased in MCI
Mild Cognitive Impairment in Clinical Practice: A Review Article.
MCI including the diagnostic criteria of MCI due to Alzheimer
Effects of APOE ε4 and amyloid pathology on longitudinal tau biomarkers, neurodegeneration, and cognitive decline in mild cognitive impairment.
MCI) confers an increased risk of Alzheimer's disease (AD). The apolipoprotein
Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.
MCI). RESULTS: The use of antihypertensive drugs was associated with
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
MCI patients. We found that MCI patients who carried the p.P522R
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment.
MCI AP+ than in MCI AP- (4.03 ± 1.07 vs 2.04 ± 0.87, p < 0.001). In a multivariate
The Effects of Transcutaneous Vagus Nerve Stimulation on Functional Connectivity Within Semantic and Hippocampal Networks in Mild Cognitive Impairment.
MCI and AD. Fifty patients with MCI (28 women) confirmed
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity.
MCI), AD dementia, or other neurodegenerative disorders were included. Tau PET with